Cytokines, Hemodynamic Parameters, & Clinical Outcomes in PAH
Aditya A. Joshi, Ryan Davey, Youlan Rao, Kai Shen, Raymond L. Benza, Amresh Raina Read Full Article » Pulmonary arterial hypertension (PAH) is a r...
Blood Based Biomarker Test to Predict Major Cardiac Events
Prevencio, Inc. has announced data published in The American Journal of Cardiology, on a new proteomic blood test that determines whether a person wil...
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
An international team of researchers used Myriad RBM’s Multi-Analyte Profile (MAP) technology to identify a pattern of cardiometabolic biomarkers that...
ENRAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease
This recent paper in the Arteriosclerosis, Thrombosis and Vascular Biology Journal of the American Heart Association describes an interesting prospect...
Biomarkers enhance prediction of cardiovascular events when added to clinical risk factors in the ORIGIN trial
Measuring large numbers of biomarkers in blood with new assay technologies may identify new biomarkers and physiologic pathways for cardiovascular eve...
New Biomarker Offers Hope for Early Detection of Cardiac Injury
Myocardial infarctions and acute coronary syndrome affect nearly 1 million Americans every year. These events result in damage to the heart tissue and...
Blood Protein May Contribute to Early Development of Atherosclerosis
A study conducted by Dr. Eric Thorin of the Montreal Heart Institute, suggests blood levels of angiopoietin-like protein 2 (angptl2) may represent an...